Im thinking another bad 4C coming CVTs way here. Maybe more delays in revenue. I wonder what TT will come up this time excuse wise. Want to buy back in but no reason to right now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential